FineHeart inks Series B

FineHeart S.A, a preclinical medical device company, has secured 15 million euros in Series B funding.

FineHeart S.A, a preclinical medical device company, has secured 15 million euros in Series B funding. The investors included Verve Ventures.

Source: Press Release